This changed for the ten-year analysis where the benefit under SRL almost reached statistical significance (SRL 81.8% vs.
← all excerpts
Early conversion to a CNI-free immunosuppression with SRL after renal transplantation-Long-term follow-up of a multicenter trial.
1
—
—